Population based treatment strategy of H pylori in Qatar: Through clinical and demographic insights
Zohaib Ahmad Khan(Hamad Medical Corporation), Shiraz Salim Khan(Hamad Medical Corporation), Anil John(University of Benin), Alia Hani Mohammed Albattah(Hamad Medical Corporation), Khalid Al-Ejji(Hamad General Hospital), Hisham Ab Ib Swehli(Saint Francis Hospital), Mohamed A. Mahmoud(Lishman Health Foundation), Rajvir Singh(Icahn School of Medicine at Mount Sinai), Saad Al Kaabi(Hamad General Hospital), Betsy Varughese(Hamad Medical Corporation)
Cited by 3
Related Papers
Artificial intelligence in medical education - perception among medical students
|BMC Medical Education|2024|121
Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo‐obstruction: A prospective study
|Journal of Gastroenterology and Hepatology|2005|73
The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole
|Annals of Tropical Medicine and Parasitology|2002|40
Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations
|Annals of Tropical Medicine and Parasitology|2000|39